• Skip to main content
  • Skip to primary sidebar
Transfusion News
  • About Us
  • Topics
    • Adverse Events (non-infectious)
    • Blood Donation
    • Cell Therapy
    • Coagulation & Plasma Transfusion
    • Platelet Transfusion
    • Policy and Guidelines
    • Quality Control and Regulatory
    • RBC Transfusion
    • Serology/Genotyping
    • Special Transfusion Situations
    • Transfusion Transmitted Infections
  • Continuing Education
  • Archives
  • Podcasts
  • Question of the Day
  • Search
  • Subscribe to Email Alerts
  • Follow us on
  • Search
  • Subscribe to Email Alerts

VIDEO: 30-Minute Rule For RBC Temperature Control May Be Too Restrictive

June 30, 2013

A study published in TRANSFUSION has found that exposure of red cell units to 30 degrees Celsius for up to 60 minutes does not cause significant damage. These findings suggest that the widely implemented 30-minute rule, which restricts the time spent outside of controlled temperature environments, may be modified without sacrificing product quality or safety.

In an accompanying editorial, Dr. Alyssa Ziman described the study. Here is Dr. Ziman:

“Many blood bankers have questioned the validity of the 30-minute rule for reissuing blood. The origin of the 30-minute rule is based on studies performed more than 50 years ago that were limited in scope and evaluated a remarkably different red cell product than what is currently available.”

Current storage guidelines in the United States and Europe specify that storage temperatures may not exceed 6 degrees Celsius, and temperatures during transport may not rise above 10 degrees

Dr. Stephen Thomas and colleagues systematically exposed adult and pediatric units to 30 degrees Celsius once, twice, or three times for 30 or 60 minutes each on 3 separate days.

The researchers found no significant differences in hemolysis between adult units exposed to elevated temperatures for 1 period of 30 or 60 minutes and units not exposed. However, exposure to 30 degrees Celsius for 2 to 3 periods of 60 minutes was associated with increased hemolysis. Pediatric units were more sensitive to ambient temperature exposure. Supernatant potassium and ATP levels were also assessed, but bacterial growth was not evaluated.

Here is Dr. Thomas: “If studies of bacterial growth do not show cause for concern then an extension of the 30 minute rule could be considered. This would most likely result in a reduction in the number of blood components that are discarded.”

Based on the research team’s findings, replacing the 30-minute rule with a 60-minute rule may be appropriate. Once again, here is Dr. Ziman:

“These findings provide the catalyst to move forward with a new rule, which would still provide a safe and viable RBC component for transfusion and allow blood bankers to responsibly conserve this scarce resource.”

We’ll be back with another edition of Transfusion News on July 15th, and until then, thanks for joining us.

References

1.    Thomas S, Hancock V, Cardigan R: The 30 minute rule for red blood cells: In vitro quality assessment after repeated exposure to 30 degrees c. Transfusion 2013;53:1169-1177.

2.    Dumani D, Goldfinger D, Ziman A: Is the 30-minute rule still applicable in the 21st century? Transfusion 2013;53:1150-1152.

Filed Under

  • Featured
  • Policy and Guidelines
  • Quality Control and Regulatory
  • RBC Transfusion
  • Videos

Recommended

  • Sex-Matched Transfusions May Reduce Mortality

  • Large-Scale Production of Red Blood Cells from Peripheral Blood Mononuclear Cells

  • ASFA Issues Updated Recommendations

Show Comments

Comments on this article are closed.

Get the latest news. Subscribe to our mailing list. Sign Up

Primary Sidebar

Latest News

  • Babesia Infection Reduces Red Cell Deformability

  • New Erythropoietin Gene Variants Linked to Hereditary Erythrocytosis

  • Multifaceted Threats to the Blood Supply from Climate Change

  • Distinct Roles for Differently Aged Platelets

    Question of the Day

    Copyright © 2025 John Wiley & Sons, Inc. All Rights Reserved.
    Privacy Policy

    Association for the Advancement of Blood and Biotherapies Wiley